| Literature DB >> 30416723 |
Israa Mohammad Abd Al-Khaliq1, Batool Mutar Mahdi1.
Abstract
BACKGROUND: Entamoeba histolytica is the parasitic amoeba which caused amebiasis in human and responsible of 100,000 deaths every year. There is currently no vaccine against this parasite. The innate and adaptive immunity are important in protection against infection. AIM OF THE STUDY: To investigate the association between HLA-DRB1 and Entamoeba histolytica infection. PATIENTS AND METHODS: The study is a case-controlled consisted from thirty Iraqi Arab Muslims patients with Entamoeba histolytica infection. The patients were consulted medical city and AL-Karama hospital for the period between May 2016 till February 2017. The control groups were sex and age matched with patient study group, they were consisted of thirty Iraqi Arab Muslims healthy individuals. HLA-DRB1 was done by SSOP method.Entities:
Keywords: Amebiasis; Entamoeba histolytica; HLA
Year: 2018 PMID: 30416723 PMCID: PMC6215996 DOI: 10.1016/j.amsu.2018.10.019
Source DB: PubMed Journal: Ann Med Surg (Lond) ISSN: 2049-0801
Fig. 1Flow diagram.
Base line characters' of the patients.
| No. = 30 | Characteristic |
|---|---|
| 31 ± 1.21 | Age (X±SEM) |
| 25 (83.3%) | Males |
| 5(16.6%) | Females |
| 27(90%) | Married |
| 3(10%) | Single |
| 30(100%) | Iraqi Nationality |
| 8(26.6%) | Governmental Workers |
| 22(73.3%) | Non Governmental Workers |
| 2(6.6%) | Rural residency |
| 28(93.3%) | Non Rural residency |
Human leukocytes antigens (HLA-DRB1) alleles frequencies in patients with Entamoeba histolytica infection and healthy control group.
| P- value | Odd ratio, (95% confidence interval) | control group No. = 30 No. % | patients group No. = 30 No. % | HLA-DRB1* alleles |
|---|---|---|---|---|
| na | na | 2 (6.66) | 0 (0) | 02:0301 |
| 0.002 | 7.42 2.07 to 26.55 | 4 (13.33) | 16 (53.33) | 03:0101 |
| na | na | 2 (6.66) | 0 (0) | 03:0102 |
| na | na | 4 (13.33) | 0 (0) | 03:1701 |
| na | na | 1 (3.33) | 0 (0) | 03:1101 |
| na | na | 0 (0) | 7 (23.33) | 04:02:01 |
| na | na | 0 (0) | 8 (26.66) | 04:03:01 |
| na | na | 7 (23.33) | 0 (0) | 07:0101 |
| na | na | 2 (6.66) | 0 (0) | 08:0101 |
| na | na | 2 (6.66) | 0 (0) | 08:0201 |
| 0.010 | 4.29 1.41 to 13.06 | 7 (23.33) | 17 (56.66) | 11:01:01 |
| na | na | 0 (0) | 1 (3.33) | 11:01:03 |
| na | na | 0 (0) | 1 (3.33) | 11:33:01 |
| na | na | 4 (13.33) | 0 (0) | 11:03:01 |
| na | na | 4 (13.33) | 0 (0) | 11:67:01 |
| na | na | 2 (6.66) | 0 (0) | 12:09:01 |
| na | na | 2 (6.66) | 0 (0) | 13:05:01 |
| na | na | 7 (23.33) | 0 (0) | 13:18:01 |
| na | na | 2 (6.66|) | 0 (0) | 14:0101 |
| na | na | 8 (26.66) | 0 (0) | 14:02:01 |
| na | na | 0 (0) | 8 (26.66) | 15:01:01 |
na = not applicable.
Significant (03:01:01, 11:01:01).